Lipotoxicity-Polarized Macrophages – Derived Mir-27-3p Contributes to Mitochondrial Fitness Dependent Pro-Inflammatory Response and Aggravates Insulin Resistance Through Miro1 /mfn Pathway

Jian-Ming Li,Lawrence Wing Chi Chan,Ruinian Hu,Xianyu Li,Chunyan Lun,Jianfeng Gao,Tian Zheng,Haojie Li,Sijun Yang
DOI: https://doi.org/10.2139/ssrn.4234691
2022-01-01
SSRN Electronic Journal
Abstract:Insulin resistance (IR) is a major pathophysiologic defect in type 2 diabetes and obesity, caused by generation of mtROS led to NLRP3 inflammasome activation. M1-like macrophages has been found to sense this blowing out mtROS and mediate downstream inflammatory under “lipotoxicity” in causing abnormal metabolic homeostasis. This paper aims to explore the role of exosomal miRNAs derived from bone marrow-derived macrophages (BMDMs) under LPS+paltimate stress in the development of NLRP3 dependent inflammatory responses and IR. Here, we show that lipotoxicity-polarized BMDMs-derived secrete miRNA-containing exosomes (Exos) leading to the accumulation of fragmented dysfunctional mitochondria, which impairs glucose tolerance and insulin sensitivity when given to WT mice and triggers significant increased pro-inflammatory chemokine and cytokine production level of IL-1β, MCP-1, IL-6, and TNF-α result from mitophagy inhibition. We found that miR-27-3p is highly expressed in M1 Exos and functions as an insulin inhibiter by leading mitochondria fission rather than fusion, as well as mitophagy impairment resulted in NLRP3 inflammatory activation and the development of IR both in vivo and in vitro. Expressing miR-27-3p mimic Exos recapitulate the effects of lipotoxicity-polarized macrophages-derived M1 Exos on metabolic phenotypes. A dual-luciferase reporter assay confirmed that Miro1 is a bona fide target mRNA of miR-27-3p, which couples to the mitochondrial transport and fusion machinery leads to abnormal mitophagy through Miro1/Mfn pathway in modulating mitophagy deficient-mediated inflammation and insulin sensitivity. Taken together, these data suggest miR-27-3p/Miro1/Mfn could be a new therapeutic target for metabolic disease.Funding Information: This study is supported by grants from the National Natural Scientific Foundation of China (grant number 81873780) , Education Department of Hunan Province (19A058), Project of Changsha Science and Technology (kq2004077), the Application Characteristic Discipline of Hunan Province to Jianming Li; by grants from the National Natural Science Foundation of China (No. 81670747), Wuhan University Top-Notch Talent Fund (2042016kf0149), Hubei Provincial Natural Fund Key Projects (2015CFA075), and Wuhan University Outstanding Talent Startup Fund (907/410100006) to Sijun Yang.Declaration of Interests: The authors declare no competing financial interests.Ethics Approval Statement: All experimental procedures were approved by Changsha Medical University Animal Care and Use Committee and were conducted in full accordance with the Guide for the Care and Use of Laboratory Animals.
What problem does this paper attempt to address?